These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6546456)

  • 21. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
    Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
    Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cigarette smoking and lung metabolism--effect of cigarette smoking on blood levels of 6-keto PGF1 alpha, thromboxane B2 and lipoperoxide in healthy volunteers].
    Ishihara Y; Kitamura S; Chijimatsu Y; Homma H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Dec; 22(12):1122-6. PubMed ID: 6549510
    [No Abstract]   [Full Text] [Related]  

  • 25. 6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue.
    Saldeen P; Saldeen T
    Thromb Res; 1983 Jun; 30(6):643-50. PubMed ID: 6688484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
    Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
    Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
    Zipser RD
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of thromboxane in primate endotoxin shock.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Surg Res; 1985 Aug; 39(2):140-9. PubMed ID: 3839548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of amnioscopy on concentrations of prostaglandin F2 alpha, prostacyclin and thromboxane in maternal plasma.
    Ylikorkala O; Viinikka L
    Gynecol Obstet Invest; 1982; 13(3):150-4. PubMed ID: 6954125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane synthase inhibition: implications for prostaglandin endoperoxide metabolism. II. Testing the 'redirection hypothesis' in an acute intravenous challenge model.
    Carey F; Haworth D
    Prostaglandins; 1986 Jan; 31(1):47-59. PubMed ID: 3754057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between thromboxane B2 and 6-keto-prostaglandin F1 alpha in sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):297-302. PubMed ID: 8008979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
    Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis of prostaglandins (TXB2 and 6-keto-PGF1 alpha) during cardiopulmonary bypass].
    Arima T; Ohata M; Ishizuka K; Sakamoto T; Hori T
    Masui; 1986 Feb; 35(2):277-85. PubMed ID: 3754591
    [No Abstract]   [Full Text] [Related]  

  • 39. [A study of the role of plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in epidemic hemorrhagic fever].
    Wang GQ; Zou ZZ; Yu DP
    Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):138-40, 188. PubMed ID: 1976492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
    Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.